• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjects

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Correction to: Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT)

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    34857017.pdf
    Size:
    565.7Kb
    Format:
    PDF
    Description:
    From UNPAYWALL
    Download
    Authors
    Hanna, C. R.
    O'Cathail, S. M.
    Graham, J. S.
    Saunders, Mark P
    Samuel, L.
    Harrison, M.
    Devlin, L.
    Edwards, J.
    Gaya, D. R.
    Kelly, C. A.
    Lewsley, L. A.
    Maka, N.
    Morrison, P.
    Dinnett, L.
    Dillon, S.
    Gourlay, J.
    Platt, J. J.
    Thomson, F.
    Adams, R. A.
    Roxburgh, C. S. D.
    Show allShow less
    Affiliation
    Cancer Research UK Glasgow Clinical Trials Unit, Beatson West of Scotland Cancer Centre, Institute of Cancer Sciences, University of Glasgow, Level 0, 1053 Great Western Road, Glasgow, G12 0YN, UK.
    Issue Date
    2021
    
    Metadata
    Show full item record
    Citation
    Hanna CR, O’Cathail SM, Graham JS, Saunders M, Samuel L, Harrison M, et al. Correction to: Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT) Vol. 16, Radiation Oncology. Springer Science and Business Media LLC; 2021.
    Journal
    Radiotherapy and Oncology
    URI
    http://hdl.handle.net/10541/624985
    DOI
    10.1186/s13014-021-01941-z
    PubMed ID
    34857017
    Type
    Other
    ae974a485f413a2113503eed53cd6c53
    10.1186/s13014-021-01941-z
    Scopus Count
    Collections
    All Christie Publications

    entitlement

    Related articles

    • Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT).
    • Authors: Hanna CR, O'Cathail SM, Graham JS, Saunders M, Samuel L, Harrison M, Devlin L, Edwards J, Gaya DR, Kelly CA, Lewsley LA, Maka N, Morrison P, Dinnett L, Dillon S, Gourlay J, Platt JJ, Thomson F, Adams RA, Roxburgh CSD
    • Issue date: 2021 Aug 26
    • Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial.
    • Authors: Altorki NK, McGraw TE, Borczuk AC, Saxena A, Port JL, Stiles BM, Lee BE, Sanfilippo NJ, Scheff RJ, Pua BB, Gruden JF, Christos PJ, Spinelli C, Gakuria J, Uppal M, Binder B, Elemento O, Ballman KV, Formenti SC
    • Issue date: 2021 Jun
    • The WIRE study a phase II, multi-arm, multi-centre, non-randomised window-of-opportunity clinical trial platform using a Bayesian adaptive design for proof-of-mechanism of novel treatment strategies in operable renal cell cancer - a study protocol.
    • Authors: Ursprung S, Mossop H, Gallagher FA, Sala E, Skells R, Sipple JAN, Mitchell TJ, Chhabra A, Fife K, Matakidou A, Young G, Walker A, Thomas MG, Ortuzar MC, Sullivan M, Protheroe A, Oades G, Venugopal B, Warren AY, Stone J, Eisen T, Wason J, Welsh SJ, Stewart GD
    • Issue date: 2021 Nov 18
    • The role of chemotherapy in localized and locally advanced rectal cancer: A systematic revision.
    • Authors: Roselló S, Papaccio F, Roda D, Tarazona N, Cervantes A
    • Issue date: 2018 Feb
    • A phase I open label dose-escalation study to evaluate the tolerability, safety and immunological efficacy of sub-urothelial durvalumab injection in adults with muscle-invasive or high-risk non-muscle-invasive bladder cancer (SUBDUE-1, SUB-urothelial DUrvalumab injection-1 study): clinical trial protocol.
    • Authors: Moe A, Liow E, Redfern A, Swarbrick N, Ferguson T, Davis ID, Hayne D
    • Issue date: 2021 Oct
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.